Clinical Trial Update: "Efficacy and Safety of Levofloxacin vs Isoniazid in Latent Tuberculosis Infection in Liver Transplant Patients". [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing levofloxacin with isoniazid for latent tuberculosis infection in liver transplant patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection in Solid Organ Transplant Recipients
• Latent Tuberculosis Infection

Drugs mentioned

• ISONIAZID (ISONIAZID)
• Levofloxacin (Levofloxacin)

Snippet

Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | Conditions: Latent Tuberculosis Infection, Infection in Solid Organ Transplant Recipients | Phase 3 | Status: TERMINATED